5728-55-2 Usage
Chemical structure
The compound is composed of a purine ring, a piperidine ring, and a tetrazole ring, with a sulfanyl group and a carboxamide group attached.
Molecular weight
Approximately 534.55 g/mol
Purine ring
A heterocyclic aromatic ring system consisting of a pyrimidine and an imidazole fused together.
Piperidine ring
A six-membered heterocyclic ring containing one nitrogen atom.
Tetrazole ring
A five-membered heterocyclic ring with four nitrogen atoms.
Sulfanyl group
A sulfur atom with a single unpaired electron, acting as a thiol group.
Carboxamide group
A functional group consisting of a carbonyl group (C=O) attached to an amine group (NH2).
Potential applications
The compound may have potential applications in pharmaceutical research and drug development due to its unique structure and potential biological activities.
Synthetic molecule
The compound is a synthetic molecule, which means it is not found naturally and is created through chemical synthesis.
Further research
The precise properties and potential uses of the compound would need to be further studied and characterized in a laboratory setting to fully understand its capabilities and limitations.
Check Digit Verification of cas no
The CAS Registry Mumber 5728-55-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,7,2 and 8 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5728-55:
(6*5)+(5*7)+(4*2)+(3*8)+(2*5)+(1*5)=112
112 % 10 = 2
So 5728-55-2 is a valid CAS Registry Number.
5728-55-2Relevant academic research and scientific papers
COMPOSITIONS AND METHODS FOR MODULATING LPA RECEPTORS
-
Page/Page column 74, (2012/10/18)
The present invention relates to compounds of Formula (1), or pharmaceutically acceptable salts thereof and their pharmaceutical compositions, wherein variables are as defined herein, which are useful as modulators of the activity of lysophosphatidic acid (LPA).
2,3-diaminopropionic acid derivative
-
, (2008/06/13)
The present invention relates to a 2,3-diaminopropionic acid derivative of the formula (1): STR1 or a pharmaceutically acceptable salt thereof. The compounds of the present invention are useful as a platelet aggregation inhibitor, a cancer metastasis inhibitor, a wound healing agent or a bone resorption inhibitor.
